Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use.
This recall has been terminated (originally issued August 31, 2012).
- Company
- Princeton Biomeditech Corp
- Recall Initiated
- March 9, 2012
- Posted
- August 31, 2012
- Terminated
- October 14, 2014
- Recall Number
- Z-2308-2012
- Quantity
- 90 kits (22 tests per kit)
- Firm Location
- Monmouth Junction, NJ
- Official Source
- View on FDA website ↗
Reason for Recall
There have been reports of dual positive (Flu A + Flu B positive) results being encountered.
Distribution
Nationwide Distribution-including the states of NJ, NY, and PA.
Lot / Code Info
510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit)
Root Cause
Nonconforming Material/Component
Action Taken
OraSure Technologies, Inc. sent an "IMPORTANT NOTICE FOR ORASURE QUICKFLU RAPID FLU A + B TEST" letter dated March 13, 2012 to all affected customers. The letter identifies the product, problem, and actions to be taken by the customers. Contact the firm at 610-882-1820 for questions concerning this recall.
More recalls by Princeton Biomeditech Corp
Osom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotr...
Oct 30, 2024